Who owns Aptevo Therapeutics Inc Com New stock?

Tip: Access positions for across all investors

Analyze quarterly positions in Aptevo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aptevo Therapeutics stock

Who bought or sold Aptevo Therapeutics Inc Com New stock this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Sabby Management 1.3M $440k 100% Sep 2023
 View chart
Armistice Capital 1.2M $408k 100% Sep 2023
 View chart
Citadel Advisors 262k $47k 100% Dec 2023
 View chart
Renaissance Technologies 176k $58k 119% Sep 2023
 View chart
Schonfeld Strategic Advisors 159k $29k 11% Dec 2023
 View chart
Squarepoint Ops 139k $25k 100% Dec 2023
 View chart
Millennium Management 105k $19k 100% Dec 2023
 View chart
Vanguard Group 92k $17k -59% Dec 2023
 View chart
Geode Capital Management 75k $25k 43% Sep 2023
 View chart
Cantor Fitzgerald, L. P. 59k $11k 4% Dec 2023
 View chart
BlackRock 48k $16k -1% Sep 2023
 View chart
Alyeska Investment Group 46k $8.3k 100% Dec 2023
 View chart
Baader Bank 15k $2.0k 100% Dec 2023
 View chart
Northern Trust 14k $4.7k -20% Sep 2023
 View chart
Tower Research Capital 14k $4.5k 806% Sep 2023
 View chart
Two Sigma Securities 11k $2.0k 100% Dec 2023
 View chart
Morgan Stanley 11k $3.6k 0% Sep 2023
 View chart
Franklin Resources 11k $2.0k 0% Dec 2023
 View chart
State Street Corporation 11k $3.6k 0% Sep 2023
 View chart
Divergent Wealth Advisors 10k $1.8k 0% Dec 2023
 View chart
Jpmorgan Chase & Co 1.9k $342.977600 -1% Dec 2023
 View chart
Wells Fargo & Company 1.6k $292.838700 4% Dec 2023
 View chart
Fifth Third Bancorp 291.00 $52.991100 0% Dec 2023
 View chart
Pnc Financial Services 142.00 $26.000200 0% Dec 2023
 View chart
Truvestments Capital 95.00 $30.998500 0% Sep 2023
 View chart
Advisor Group Holdings 30.00 $5.001000 0% Dec 2023
 View chart
Hanson McClain Advisors 17.00 $4.000100 0% Dec 2023
 View chart
Citigroup 10.00 $2.000000 0% Dec 2023
 View chart
Bank of America Corporation 6.00 $1.000200 0% Dec 2023
 View chart
UBS Group 5.00 $1.000000 -94% Dec 2023
 View chart

Who sold out of Aptevo Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
T. Rowe Price Associates Sep 2023 46k $16k
Earnest Partners Sep 2023 14.00 $4.999400